Viral Hepatitis C - AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases

AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases
[Press Release] Business Wire via Yahoo! Finance - Mar 13 6:00 AM
PORTLAND, Ore.----March 13, 2006--AVI BioPharma, Inc. , today announced that it has entered into agreements with Cook Group Inc. for Cook's development and commercialization of products for vascular diseases.Save to My Web

Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year results: Good progress
n-tv.de - Mar 05 10:31 PM
Disclosure announcement transmitted by euro adhoc.Save to My Web

MedMira Secures $6.5M in Institutional Equity Financing
[Press Release] PR Newswire via Yahoo! Finance - Mar 06 5:52 AM
MedMira Inc., the global market leader in premium rapid diagnostic solutions, announced today that it has secured $6.5 million in equity financing from the Morningside group, an international private equity and venture capital investment group.Save to My Web

AVI BioPharma partners to commercialize heart therapies
bizjournals.com via Yahoo! Finance - 39 minutes ago
AVI BioPharma Inc. has an agreement with Cook Group Inc. in which Cook will develop and commercialize AVI's treatments for vascular diseases.Save to My Web